A Study of BIBW 2992 (Afatinib) in Patients With Metastatic Colorectal Cancer

Clinical trial NCT01152437 · COMPLETED

Trial details

NCT number: NCT01152437
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Neoplasms

Start date: 2010-06-01
Primary completion: 2012-03-01
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.